In a significant turn in one of London’s most closely watched shareholder battles of 2025, proxy adviser Glass Lewis has recommended that investors in Third Point Investors Limited vote in favor of the proposed acquisition of Malibu Life Reinsurance SPC. The August 14 vote could transform the London-listed investment trust, managed by billionaire hedge-fund manager Daniel Loeb, into a fully fledged reinsurance company with a strategic focus on the U.S. fixed-annuity market.
The recommendation marks a critical moment in the campaign for shareholder approval. It comes just days after rival proxy adviser Institutional Shareholder Services (ISS) urged investors to reject the proposal, warning that the transaction could fundamentally alter the trust’s investment profile without providing minority shareholders with a full exit option.
Why is Glass Lewis supporting Third Point Investors Limited’s proposed Malibu Life Reinsurance acquisition despite investor concerns?
Glass Lewis, one of the world’s most influential proxy advisory firms, cited multiple reasons for its endorsement. Its report noted that the post-merger voting power of Third Point would remain capped at approximately 30 percent, a governance safeguard intended to prevent undue control by insiders. It also highlighted Third Point’s $30 million equity injection into the transaction as a sign of long-term commitment from Loeb and his team.
In the view of Glass Lewis, Malibu Life brings experienced management, strong underwriting capabilities, and established partnerships with seasoned reinsurers. These attributes, it argued, could provide Third Point Investors Limited with stable, fee-based income streams that are less volatile than traditional hedge-fund returns.
The proposed deal is structured as an all-share reverse takeover valued at about $68 million. Malibu Life, founded in 2024 by Third Point’s hedge-fund operations, specializes in reinsuring fixed annuities—products that match long-term liabilities with long-duration assets, aligning well with Third Point’s credit and structured-product investment expertise.
What are the main criticisms from Institutional Shareholder Services and activist investor groups regarding the Malibu Life Reinsurance deal?
In stark contrast, ISS’s advisory report urged shareholders to vote against the acquisition. It argued that transforming Third Point Investors Limited from a closed-end investment trust into a reinsurance company represents a “fundamental change” to the trust’s investment mandate. ISS warned that the pivot carries significant operational and regulatory risks for investors more familiar with traditional asset-management strategies.
Beyond ISS, activist investor Asset Value Investors Limited (AVI)—which holds roughly 7 percent of the trust—has been vocal in its opposition. AVI has criticized the deal as a governance misstep and demanded a full cash exit for shareholders who prefer not to participate in the reinsurance business. It also called for the vote to exclude shares held by Third Point itself, arguing that this would ensure an independent decision by outside investors.
The board has since adjusted the Redemption Offer in response to these pressures. Cash outlays for dissenting shareholders have been increased to $136 million, with the redemption price set at roughly 95 percent of the trust’s reference net asset value. While this is a marked improvement from the original offer, AVI maintains that it still falls short of granting a true full-exit option.
How would the acquisition of Malibu Life Reinsurance change Third Point Investors Limited’s revenue model and sector positioning?
Third Point Investors Limited currently operates as a conduit for Daniel Loeb’s hedge-fund strategies, generating returns from equity, credit, and event-driven investments. If the deal is approved, the trust would effectively become a hybrid asset-management and reinsurance platform.
The U.S. fixed-annuity market—valued at over $250 billion annually—offers recurring premium flows and long-term asset-liability matching opportunities. For Third Point, reinsuring these annuities could provide a more predictable earnings profile, less tied to market volatility. This diversification could also reduce reliance on performance fees, which have been under pressure across the hedge-fund industry due to lower volatility and reduced arbitrage opportunities.
The shift would also place the trust into a more regulated environment. U.S. reinsurance operations are subject to stringent capital requirements, actuarial reserve rules, and oversight by multiple state insurance regulators. This new compliance landscape could pose both a challenge and a safeguard, depending on execution.
What is the market and institutional investor sentiment ahead of the August 14 shareholder vote?
Market reaction to date has been cautious. Shares of Third Point Investors Limited on the London Stock Exchange have traded largely sideways since the announcement, with the trust’s discount to net asset value hovering around 17 percent. This suggests that investors are still weighing the potential long-term earnings stability against the risks of entering a highly specialized and regulated industry.
Institutional sentiment appears divided. Supporters point to the success of other asset managers that have entered the reinsurance space, such as Apollo Global Management’s Athene platform, which has generated stable returns through annuity reinsurance. Critics, however, warn that insurance underwriting is fundamentally different from hedge-fund investing, with its own set of operational, actuarial, and capital-management complexities.
What could be the potential outcomes for Third Point Investors Limited if the Malibu Life Reinsurance deal is approved or rejected?
If approved, the deal would mark the first creation of a new London-listed insurer since 2020 and could position Third Point as a leader in combining alternative-investment expertise with insurance-linked capital. The immediate benefits could include recurring fee income, enhanced scale in U.S. credit markets, and a more diversified revenue mix. Over time, the reinsurance arm could help narrow the trust’s NAV discount if investors gain confidence in the stability of cash flows.
If rejected, Third Point Investors Limited would likely continue operating as a closed-end investment trust, leaving its NAV discount and capital-structure challenges unresolved. A failed vote could also prompt renewed activist pressure to overhaul governance or pursue alternative strategies to unlock value, such as more aggressive buybacks or liquidation proposals.
How does this move fit into the broader trend of hedge funds seeking permanent capital through insurance vehicles?
Third Point’s strategic pivot reflects a broader movement among alternative asset managers to secure permanent capital through insurance-linked entities. Insurance and reinsurance platforms provide a steady inflow of investable assets via premiums, enabling managers to invest over longer horizons without the redemption pressures of traditional hedge-fund structures.
This model has gained traction as firms like Apollo, KKR, and Blackstone have scaled their insurance operations to billions in assets under management. By marrying asset-management capabilities with insurance liabilities, these firms have created diversified earnings streams less dependent on market cycles.
For Daniel Loeb, the Malibu Life transaction could be a way to replicate such success on a more focused scale, targeting a segment—U.S. fixed annuities—that offers strong demand and favorable asset-liability matching characteristics.
What are the key risks and governance considerations if the transaction moves forward?
The reinsurance industry carries risks that are less familiar to traditional equity investors. Mispricing annuity risks, underestimating reserve requirements, or failing to meet regulatory capital standards can have significant financial consequences.
Governance will also be a critical factor. With Third Point holding close to 30 percent of voting rights post-transaction, the independence and oversight of the board will be under scrutiny. Glass Lewis’ endorsement assumes that governance safeguards will remain robust, but dissenting investors argue that ongoing transparency will be essential to maintain trust.
Discover more from Business-News-Today.com
Subscribe to get the latest posts sent to your email.